Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease

Frontiers in Aging Neuroscience

Volumn 6, Issue MAY, 2014, Pages

  Benazzouz, Abdelhamid ^a,b   Mamad, Omar ^a,b,c   Abedi, Pamphyle ^a,b,c   Bouali Benazzouz, Rabia ^d   Chetrit, Jonathan ^a,b  

^a INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^b CNRS   (France)

^c FACULTÉ DES SCIENCES   (Morocco)

^d University of Bordeaux   (France)

Author keywords

basal ganglia; dopamine; extrastriatal dopamine; globus pallidus; Parkinson's disease; subthalamic nucleus

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 5 RECEPTOR; FLUPENTIXOL;

BASAL GANGLION; CAUDATE NUCLEUS; DOPAMINERGIC TRANSMISSION; GLOBUS PALLIDUS; HUMAN; LOCOMOTION; MOTOR CONTROL; MOTOR DYSFUNCTION; NONHUMAN; OROFACIAL DYSKINESIA; PARKINSON DISEASE; PATHOPHYSIOLOGY; RETROGRADE DEGENERATION; SHORT SURVEY; SUBTHALAMIC NUCLEUS; UPREGULATION;

EID: 84901379033     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00087     Document Type: Short Survey

References (69)

1. Abedi, P. M., Delaville, C., De Deurwaerdere, P., Benjelloun, W., and Benazzouz, A. (2013). Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat. Neuroscience 236, 289-297. doi: 10.1016/j.neuroscience.2013.01.043
2. Agid, Y., and Blin, J. (1987). Nerve cell death in degenerative diseases of the central nervous system: clinical aspects. Ciba Found. Symp. 126, 3-29. doi: 10.1002/9780470513422.ch2
3. Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375. doi: 10.1016/0166-2236(89)90074-x
4. Alexander, G. E., and Crutcher, M. D. (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266-271. doi: 10.1016/0166-2236(90)90107-l
5. Anaya-Martinez, V., Martinez-Marcos, A., Martinez-Fong, D., Aceves, J., and Erlij, D. (2006). Substantia nigra compacta neurons that innervate the reticular thalamic nucleus in the rat also project to striatum or globus pallidus: implications for abnormal motor behavior. Neuroscience 143, 477-486. doi: 10.1016/j.neuroscience.2006.08.033
6. Baufreton, J., Garret, M., Rivera, A., De La Calle, A., Gonon, F., Dufy, B., et al. (2003). D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J. Neurosci. 23, 816-825.
7. Baufreton, J., Zhu, Z. T., Garret, M., Bioulac, B., Johnson, S. W., and Taupignon, A. I. (2005). Dopamine receptors set the pattern of activity generated in subthalamic neurons. FASEB J. 19, 1771-1777. doi: 10.1096/fj.04-3401hyp
8. Benazzouz, A., Breit, S., Koudsie, A., Pollak, P., Krack, P., and Benabid, A. L. (2002). Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov. Disord. 17(Suppl. 3), S145-S149. doi: 10.1002/mds.10156
9. Benazzouz, A., Gross, C., Feger, J., Boraud, T., and Bioulac, B. (1993). Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5, 382-389. doi: 10.1111/j.1460-9568.1993.tb00505.x
10. Bergman, H., Wichmann, T., and Delong, M. R. (1990). Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438. doi: 10.1126/science.2402638
11. Bergman, H., Wichmann, T., Karmon, B., and Delong, M. R. (1994). The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 72, 507-520.
12. Bézard, E., Ferry, S., Mach, U., Stark, H., Leriche, L., Boraud, T., et al. (2003). Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat. Med. 9, 762-767. doi: 10.1038/nm875
13. Bokobza, B., Ruberg, M., Scatton, B., Javoy-Agid, F., and Agid, Y. (1984). [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. Eur. J. Pharmacol. 99, 167-175. doi: 10.1016/0014-2999(84)90238-3
14. Boraud, T., Bezard, E., Guehl, D., Bioulac, B., and Gross, C. (1998). Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res. 787, 157-160. doi: 10.1016/s0006-8993(97)01563-1
15. Bouali-Benazzouz, R., Tai, C. H., Chetrit, J., and Benazzouz, A. (2009). Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus. Neuroscience 164, 588-596. doi: 10.1016/j.neuroscience.2009.07.034
16. Breit, S., Bouali-Benazzouz, R., Popa, R. C., Gasser, T., Benabid, A. L., and Benazzouz, A. (2007). Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp. Neurol. 205, 36-47. doi: 10.1016/j.expneurol.2006.12.016
17. Chetrit, J., Taupignon, A., Froux, L., Morin, S., Bouali-Benazzouz, R., Naudet, F., et al. (2013). Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease. J. Neurosci. 33, 14840-14849. doi: 10.1523/JNEUROSCI.0453-13.2013
18. Cortés, R., Camps, M., Gueye, B., Probst, A., and Palacios, J. M. (1989). Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology. Brain Res. 483, 30-38. doi: 10.1016/0006-8993(89)90031-0
19. Cossette, M., Levesque, M., and Parent, A. (1999). Extrastriatal dopaminergic innervation of human basal ganglia. Neurosci. Res. 34, 51-54. doi: 10.1016/s0168-0102(99)00029-2
20. Debeir, T., Ginestet, L., Francois, C., Laurens, S., Martel, J. C., Chopin, P., et al. (2005). Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus. Exp. Neurol. 193, 444-454. doi: 10.1016/j.expneurol.2005.01.007
21. DeLong, M. R. (1990). Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285. doi: 10.1016/0166-2236(90)90110-v
22. Demchyshyn, L. L., Mcconkey, F., and Niznik, H. B. (2000). Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. J. Biol. Chem. 275, 23446-23455. doi: 10.1074/jbc.m000157200
23. Flores, G., Liang, J. J., Sierra, A., Martinez-Fong, D., Quirion, R., Aceves, J., et al. (1999). Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience 91, 549-556. doi: 10.1016/s0306-4522(98)00633-2
24. Flores, G., Valencia, J., Rosales, M. G., Sierra, A., and Aceves, J. (1993). Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat. Neurosci. Lett. 162, 153-156. doi: 10.1016/0304-3940(93)90583-7
25. François, C., Savy, C., Jan, C., Tande, D., Hirsch, E. C., and Yelnik, J. (2000). Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys and in Parkinson's disease patients. J. Comp. Neurol. 425, 121-129. doi: 10.1002/1096-9861(20000911)425:1<121::aid-cne10>3.0.co;2-g
26. François, C., Yelnik, J., Tande, D., Agid, Y., and Hirsch, E. C. (1999). Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum. J. Comp. Neurol. 414, 334-347. doi: 10.1002/(sici)1096-9861(19991122)414:3<334::aid-cne4>3.3.co;2-o
27. Fuchs, H., and Hauber, W. (2004). Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. Exp. Brain Res. 154, 66-75. doi: 10.1007/s00221-003-1638-7
28. Galvan, A., Floran, B., Erlij, D., and Aceves, J. (2001). Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J. Neural Transm. 108, 153-166. doi: 10.1007/s007020170085
29. Hauber, W. (1998). Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats. Neuroreport 9, 4115-4118. doi: 10.1097/00001756-199812210-00020
30. Hauber, W., and Lutz, S. (1999). Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav. Brain Res. 106, 143-150. doi: 10.1016/s0166-4328(99)00102-3
31. Hauber, W., Lutz, S., and Munkle, M. (1998). The effects of globus pallidus lesions on dopamine-dependent motor behaviour in rats. Neuroscience 86, 147-157. doi: 10.1016/s0306-4522(98)00009-8
32. Hedreen, J. C. (1999). Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J. Comp. Neurol. 409, 400-410. doi: 10.1002/(sici)1096-9861(19990705)409:3<400::aid-cne5>3.0.co;2-4
33. Hornykiewicz, O. (1998). Biochemical aspects of Parkinson's disease. Neurology 51, S2-S9. doi: 10.1212/WNL.51.2_Suppl_2.S2
34. Hurley, M. J., Mash, D. C., and Jenner, P. (2001). Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease. Brain Res. Mol. Brain Res. 87, 271-279. doi: 10.1016/s0169-328x(01)00022-5
35. Hutchison, W. D., Allan, R. J., Opitz, H., Levy, R., Dostrovsky, J. O., Lang, A. E., et al. (1998). Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann. Neurol. 44, 622-628. doi: 10.1002/ana.410440407
36. Jan, C., Francois, C., Tande, D., Yelnik, J., Tremblay, L., Agid, Y., et al. (2000). Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur. J. Neurosci. 12, 4525-4535. doi: 10.1111/j.1460-9568.2000.01351.x
37. Kebabian, J. W., and Calne, D. B. (1979). Multiple receptors for dopamine. Nature 277, 93-96. doi: 10.1038/277093a0
38. Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., et al. (2003). Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 349, 1925-1934. doi: 10.1056/nejmoa035275
39. Lavoie, B., Smith, Y., and Parent, A. (1989). Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry. J. Comp. Neurol. 289, 36-52. doi: 10.1002/cne.902890104
40. Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J. F., Broussolle, E., et al. (1995). Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345, 91-95. doi: 10.1016/s0140-6736(95)90062-4
41. Lindvall, O., and Bjorklund, A. (1979). Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res. 172, 169-173. doi: 10.1016/0006-8993(79)90907-7
42. Magill, P. J., Bolam, J. P., and Bevan, M. D. (2001). Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 106, 313-330. doi: 10.1016/s0306-4522(01)00281-0
43. Marin, C., Bonastre, M., Mengod, G., Cortes, R., Rodriguez-Oroz, M. C., and Obeso, J. A. (2013). Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease. Exp. Neurol. 250, 304-312. doi: 10.1016/j.expneurol.2013.10.006
44. Mehta, A., Thermos, K., and Chesselet, M. F. (2000). Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions. Synapse 37, 298-307. doi: 10.1002/1098-2396(20000915)37:4<298::aid-syn7>3.0.co;2-a
45. Moore, R. Y., Whone, A. L., and Brooks, D. J. (2008). Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study. Neurobiol. Dis. 29, 381-390. doi: 10.1016/j.nbd.2007.09.004
46. Ni, Z., Bouali-Benazzouz, R., Gao, D., Benabid, A. L., and Benazzouz, A. (2000). Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur. J. Neurosci. 12, 4338-4344. doi: 10.1111/j.1460-9568.2000.01346.x
47. Ni, Z., Bouali-Benazzouz, R., Gao, D., Benabid, A. L., and Benazzouz, A. (2001a). Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat. Synapse 40, 145-153. doi: 10.1002/syn.1036
48. Ni, Z. G., Bouali-Benazzouz, R., Gao, D. M., Benabid, A. L., and Benazzouz, A. (2001b). Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. Brain Res. 899, 142-147. doi: 10.1016/s0006-8993(01)02219-3
49. Nobin, A., and Bjorklund, A. (1973). Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol. Scand. Suppl. 388, 1-40.
50. Parent, A., Lavoie, B., Smith, Y., and Bedard, P. (1990). The dopaminergic nigropallidal projection in primates: distinct cellular origin and relative sparing in MPTP-treated monkeys. Adv. Neurol. 53, 111-116.
51. Parent, A., and Smith, Y. (1987). Differential dopaminergic innervation of the two pallidal segments in the squirrel monkey (Saimiri sciureus). Brain Res. 426, 397-400. doi: 10.1016/0006-8993(87)90896-1
52. Parent, A., Smith, Y., Filion, M., and Dumas, J. (1989). Distinct afferents to internal and external pallidal segments in the squirrel monkey. Neurosci. Lett. 96, 140-144. doi: 10.1016/0304-3940(89)90047-5
53. Parry, T. J., Eberle-Wang, K., Lucki, I., and Chesselet, M. F. (1994). Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp. Neurol. 128, 181-190. doi: 10.1006/exnr.1994.1126
54. Pavese, N., Rivero-Bosch, M., Lewis, S. J., Whone, A. L., and Brooks, D. J. (2011). Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study. Neuroimage 56, 1463-1468. doi: 10.1016/j.neuroimage.2011.03.012
55. Pifl, C., Bertel, O., Schingnitz, G., and Hornykiewicz, O. (1990). Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurochem. Int. 17, 263-270. doi: 10.1016/0197-0186(90)90148-m
56. Pifl, C., Reither, H., and Hornykiewicz, O. (1991). Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. Eur. J. Pharmacol. 202, 273-276. doi: 10.1016/0014-2999(91)90304-9
57. Rajput, A. H., Sitte, H. H., Rajput, A., Fenton, M. E., Pifl, C., and Hornykiewicz, O. (2008). Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 70, 1403-1410. doi: 10.1212/01.wnl.0000285082.18969.3a
58. Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P. K., Ashburner, J., et al. (1999). Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. Brain 122(Pt. 9), 1637-1650. doi: 10.1093/brain/122.9.1637
59. Rinne, J. O., Rinne, J. K., Laakso, K., Lonnberg, P., and Rinne, U. K. (1985). Dopamine D-1 receptors in the parkinsonian brain. Brain Res. 359, 306-310. doi: 10.1016/0006-8993(85)91441-6
60. Rivlin-Etzion, M., Elias, S., Heimer, G., and Bergman, H. (2010). Computational physiology of the basal ganglia in Parkinson's disease. Prog. Brain Res. 183, 259-273. doi: 10.1016/s0079-6123(10)83013-4
61. Rommelfanger, K. S., and Wichmann, T. (2010). Extrastriatal dopaminergic circuits of the Basal Ganglia. Front. Neuroanat. 4:139. doi: 10.3389/fnana.2010.00139
62. Ryoo, H. L., Pierrotti, D., and Joyce, J. N. (1998). Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Mov. Disord. 13, 788-797. doi: 10.1002/mds.870130506
63. Sañudo-Peña, M. C., and Walker, J. M. (1998). Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse 28, 27-32. doi: 10.1002/(sici)1098-2396(199801)28:1<27::aid-syn4>3.3.co;2-8
64. Smith, Y., and Villalba, R. (2008). Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov. Disord. 23(Suppl. 3), S534-S547. doi: 10.1002/mds.22027
65. Surmeier, D. J., Ding, J., Day, M., Wang, Z., and Shen, W. (2007). D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228-235. doi: 10.1016/j.tins.2007.03.008
66. Tiberi, M., and Caron, M. G. (1994). High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J. Biol. Chem. 269, 27925-27931.
67. Whone, A. L., Moore, R. Y., Piccini, P. P., and Brooks, D. J. (2003). Plasticity of the nigropallidal pathway in Parkinson's disease. Ann. Neurol. 53, 206-213. doi: 10.1002/ana.10427
68. Wichmann, T., Bergman, H., and Delong, M. R. (1994). The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism. J. Neurophysiol. 72, 521-530.
69. Wilson, C. J., and Bevan, M. D. (2011). Intrinsic dynamics and synaptic inputs control the activity patterns of subthalamic nucleus neurons in health and in Parkinson's disease. Neuroscience 198, 54-68. doi: 10.1016/j.neuroscience.2011.06.049